Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Medtronic
Johnson and Johnson
Merck
Mallinckrodt

Last Updated: May 26, 2022

Investigational Drug Information for Trehalose-6-Phosphate


✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for Trehalose-6-Phosphate?

Trehalose-6-Phosphate is an investigational drug.

There have been 15 clinical trials for Trehalose-6-Phosphate. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2022.

The most common disease conditions in clinical trials are Alzheimer Disease, Macular Edema, and Non-alcoholic Fatty Liver Disease. The leading clinical trial sponsors are Seelos Therapeutics, Inc., Bioblast Pharma Ltd., and Mashhad University of Medical Sciences.

There are fifteen US patents protecting this investigational drug and eighty-seven international patents.

Recent Clinical Trials for Trehalose-6-Phosphate
TitleSponsorPhase
SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's DiseaseSeelos Therapeutics, Inc.Phase 2
SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's DiseaseNeuroscience Trials AustraliaPhase 2
Efficacy of Oral Administration of Trehalose in Patients With Parkinson DiseaseNeuromed IRCCSPhase 4

See all Trehalose-6-Phosphate clinical trials

Clinical Trial Summary for Trehalose-6-Phosphate

Top disease conditions for Trehalose-6-Phosphate
Top clinical trial sponsors for Trehalose-6-Phosphate

See all Trehalose-6-Phosphate clinical trials

US Patents for Trehalose-6-Phosphate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Trehalose-6-Phosphate See Plans and Pricing Modified gram positive bacteria and uses thereof INTREXON ACTOBIOTICS NV (Zwijnaarde, BE) See Plans and Pricing
Trehalose-6-Phosphate See Plans and Pricing Processes of producing fermentation products NOVOZYMES A/S (Bagsvaerd, DK) See Plans and Pricing
Trehalose-6-Phosphate See Plans and Pricing Modified gram positive bacteria and uses thereof INTREXON ACTOBIOTICS NV (Zwijnaarde, BE) See Plans and Pricing
Trehalose-6-Phosphate See Plans and Pricing Production of trehalose in plants Mogen International NV (Leiden, NL) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Trehalose-6-Phosphate

Drugname Country Document Number Estimated Expiration Related US Patent
Trehalose-6-Phosphate Denmark DK2758512 2031-09-23 See Plans and Pricing
Trehalose-6-Phosphate European Patent Office EP2758512 2031-09-23 See Plans and Pricing
Trehalose-6-Phosphate Spain ES2676707 2031-09-23 See Plans and Pricing
Trehalose-6-Phosphate Hungary HUE038830 2031-09-23 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Medtronic
Johnson and Johnson
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.